Amisulpride: ook in Nederland een behandeloptie voor patiënten met een psychotische stoornis

Translated title of the contribution: Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands

C H Vinkers, I E Sommer

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

BACKGROUND: The antipsychotic drug amisulpride has not yet been officially approved for use in the Netherlands, although it is already available in other European countries , including Belgium, the UK and Germany. However, a fast-track procedure has recently been initiated so that amisulpride will soon become available in the Netherlands as well.

AIM: To summarise the efficacy and side effects of amisulpride.

METHOD: We discuss the evidence presented in the scientific literature.

RESULTS: The scientific literature assures us that amisulpride is an effective antipsychotic drug with an acceptable range of side-effects. This means that there are two main advantages that ensue from the use of amisulpride: a patient's psychosis is more likely to go into remission and patients are less likely to stop taking the drug.

CONCLUSION: The availability of amisulpride in the Netherlands will constitute a valuable addition to the pharmacotherapeutic options for treating psychotic disorders in our county.

Original languageDutch
Pages (from-to)830-4
Number of pages5
JournalTijdschrift voor Psychiatrie
Volume57
Issue number11
Publication statusPublished - 2015
Externally publishedYes

Cite this